How Often Do I Need Quinquaud FD Follow-Up Visits?
At a Glance
Follow-up for Quinquaud folliculitis decalvans has no single schedule. Visits are often every 4–8 weeks during active inflammation or after a treatment change, then every 3–6 months when stable. Your dermatologist also monitors symptoms, hair loss, and medication safety.
In this answer
4 sections
Because Quinquaud folliculitis decalvans (FD) is a chronic condition that can relapse, regular follow-up is essential to control inflammation and limit further permanent hair loss. There is no single universal appointment schedule. Instead, your dermatologist will individualize your visit frequency based on your medications, any side effects, and how quickly your condition changes [1]. As an illustrative example, during periods of active inflammation or when starting a new treatment, visits are often scheduled every 4 to 8 weeks. Once your condition reaches a stable period with minimal or no active inflammation, visits can often be spaced out to every 3 to 6 months [2].
What Your Dermatologist Will Monitor
At each visit, your doctor will evaluate whether your condition is improving, worsening, or remaining stable [3]. Because the primary goal of treatment is to halt inflammation and prevent further scarring (rather than regrowing hair from already scarred follicles), a stable bald patch means the treatment is working [1]. Your doctor will carefully track:
- Inflammatory Signs: The presence of redness, crusting, and new pustules (pus-filled bumps) [3]. While pustules are a useful sign of disease activity, your doctor will judge your overall severity based on your full examination, your symptoms, and your hair loss progression [3].
- Physical Symptoms: Changes in pain, itching, burning, or trichodynia (scalp tenderness or pain) [4].
- Scarring and Hair Loss: The size and spread of the alopecic (bald) patches [5].
- Microscopic Changes: Your doctor may use trichoscopy (a handheld magnification tool) to look closely at your scalp. This helps identify tufted hairs (multiple hairs emerging from a single follicle) and perifollicular fibrosis (scarring around the hair shaft) [6] [7]. They may also take photographs to provide a standardized record for comparison over time, though these images are used alongside (not as a replacement for) a clinical exam.
Medication Monitoring and Lab Tests
Because FD management often requires long-term medication, follow-up visits focus heavily on treatment safety. Never stop, taper, or change your medication without discussing it with your prescribing doctor, as abrupt changes can be unsafe.
- Taking Medicine as Prescribed: Your doctor will ask if you have missed doses or experienced any side effects.
- Laboratory Tests: Blood tests are determined by your specific medications, not the disease itself [1]. For instance, isotretinoin requires strict pregnancy testing as well as liver and cholesterol checks; dapsone requires a baseline test for an enzyme called G6PD and regular blood counts; and prolonged oral antibiotics may require periodic liver checks [1]. Your prescriber will provide a drug-specific monitoring plan.
- Bacterial Cultures: FD is a chronic inflammatory condition, not just a simple infection [1]. However, bacteria like Staphylococcus aureus are often involved. If your pustules persist, your doctor may swab your scalp for a bacterial culture to identify the organism and help guide antibiotic choices [8] [9].
Preparing for Your Visit
To make the most of your follow-up, bring a brief checklist to your appointment:
- The names and doses of every medicine and supplement you currently take.
- A record of any missed doses or new side effects.
- A timeline of when any new pustules, pain, or itching appeared.
When to Seek Medical Care Sooner
FD is a relapsing condition, and flares can happen even after months of stability [8]. Contact your dermatologist’s office before your next scheduled visit if you notice:
- New pustules or crusts on your scalp.
- A noticeable increase in scalp pain, burning, or itching.
- Visible expansion of your bald patches.
- Mild but concerning side effects from your medications.
Seek urgent or emergency medical care if you experience severe medication reactions or red flags, such as:
- Trouble breathing or facial swelling.
- A severe, blistering skin rash.
- Severe weakness, fainting, or sudden shortness of breath.
- Yellowing of the skin or eyes.
Common questions in this guide
How often should I have follow-up visits for Quinquaud folliculitis decalvans?
What will my dermatologist check at each follow-up visit?
What does a stable bald patch mean in folliculitis decalvans?
Which tests might I need during medication monitoring?
When should I call my dermatologist before my next appointment?
When do medication reactions require urgent care?
Related questions
Show more
Get notified when new evidence is published on Quinquaud folliculitis decalvans.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (9)
- 1
Management of folliculitis decalvans: The EADV task force on hair diseases position statement.
Waśkiel-Burnat A, Starace M, Iorizzo M, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2025; (39(8)):1385-1394 doi:10.1111/jdv.20687.
PMID: 40230058 - 2
Navigating Treatments in Folliculitis Decalvans: A Comprehensive Systematic Review.
Al-Naesan I, Trafoier T, Krepper D, et al.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2026; doi:10.1111/ddg.70607.
PMID: 42750403 - 3
Folliculitis decalvans: a multicentre review of 82 patients.
Vañó-Galván S, Molina-Ruiz AM, Fernández-Crehuet P, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2015; (29(9)):1750-7 doi:10.1111/jdv.12993.
PMID: 25682915 - 4
Successful Treatment with Fusidic Acid in a Patient with Folliculitis Decalvans.
Pimenta R, Borges-Costa J
Acta dermatovenerologica Croatica : ADC 2019; (27(1)):49-50.
PMID: 31032795 - 5
Folliculitis decalvans: Effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up.
Miguel-Gómez L, Rodrigues-Barata AR, Molina-Ruiz A, et al.
Journal of the American Academy of Dermatology 2018; (79(5)):878-883 doi:10.1016/j.jaad.2018.05.1240.
PMID: 29864465 - 6
Non-invasive Assessment and Management of Folliculitis Decalvans by Trichoscopy and Reflectance Confocal Microscopy.
Piscazzi F, Franceschini C, Narcisi A, et al.
Dermatology practical & conceptual 2024; (14(3)) doi:10.5826/dpc.1403a167.
PMID: 39122540 - 7
Histopathologic and dermoscopic features of 42 cases of folliculitis decalvans: A case series.
Uchiyama M, Harada K, Tobita R, et al.
Journal of the American Academy of Dermatology 2021; (85(5)):1185-1193 doi:10.1016/j.jaad.2020.03.092.
PMID: 32272176 - 8
Diagnostic delay, comorbid hidradenitis suppurativa and the prognostic value of bacterial culture in folliculitis decalvans: A cohort study.
Lyakhovitsky A, Segal O, Galili E, et al.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2023; (21(12)):1469-1477 doi:10.1111/ddg.15202.
PMID: 37875786 - 9
Gram-negative infections in patients with folliculitis decalvans: a subset of patients requiring alternative treatment.
Samrao A, Mirmirani P
Dermatology online journal 2020; (26(2)).
PMID: 32239885
This page explains follow-up and medication monitoring for Quinquaud folliculitis decalvans for informational purposes only and does not replace medical advice. Your dermatologist should set your visit schedule and advise you about symptoms or medication reactions.